Literature DB >> 10654450

From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes.

N Gattermann1.   

Abstract

A primary mitochondrial defect may be pivotal in the pathogenesis of acquired idiopathic sideroblastic anemia (AISA). The mitochondrial respiratory chain is involved in mitochondrial iron uptake and supply of ferrous iron (Fe2+) for heme synthesis. Mitochondrial DNA (mtDNA) comes into play because several subunits of the respiratory chain are encoded by the mitochondrial genome. We have identified heteroplasmic mutations of mtDNA, which may not only impair mitochondrial iron metabolism and heme synthesis, but through impairment of mitochondrial energy production may have much broader implications for MDS pathogenesis. For example, increased apoptosis and genetic instability may be phenomena linked to mitochondrial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10654450     DOI: 10.1016/s0145-2126(99)00160-5

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  22 in total

1.  Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype.

Authors:  Charlie Mantel; Steven Messina-Graham; Akira Moh; Scott Cooper; Giao Hangoc; Xin-Yuan Fu; Hal E Broxmeyer
Journal:  Blood       Date:  2012-06-04       Impact factor: 22.113

2.  Single cell PCR from archival stained bone marrow slides: a method for molecular diagnosis and characterization.

Authors:  Stefanie Zanssen
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

3.  Mitochondrial DNA spectra of single human CD34+ cells, T cells, B cells, and granulocytes.

Authors:  Yoji Ogasawara; Kazutaka Nakayama; Magdalena Tarnowka; J Philip McCoy; Sachiko Kajigaya; Barbara C Levin; Neal S Young
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

Review 4.  Mitophagy in hematopoietic stem cells: the case for exploration.

Authors:  Aashish Joshi; Mondira Kundu
Journal:  Autophagy       Date:  2013-10-11       Impact factor: 16.016

Review 5.  Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.

Authors:  R Tehranchi
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

6.  Role of heteroplasmic mutations in the mitochondrial genome and the ID4 gene promoter methylation region in the pathogenesis of chronic aplastic anemia in patients suffering from Kidney yin deficiency.

Authors:  Xing Cui; Jing-Yi Wang; Kui Liu; Si-Yuan Cui; Jie Zhang; Ya-Qin Luo; Xin Wang
Journal:  Chin J Integr Med       Date:  2015-04-29       Impact factor: 1.978

Review 7.  Chromosome and molecular abnormalities in myelodysplastic syndromes.

Authors:  Pierre Fenaux
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

Review 8.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

Review 9.  Oxidative stress and the myelodysplastic syndromes.

Authors:  Morag J Farquhar; David T Bowen
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

10.  Purification and characterization of sideroblasts from patients with acquired and hereditary sideroblastic anaemia.

Authors:  Florent M Martin; Josef Prchal; Jorge Nieva; Alan Saven; Jeffrey Andrey; Kelly Bethel; James C Barton; Gow Aripally; Sylvia S Bottomley; Jeffrey S Friedman
Journal:  Br J Haematol       Date:  2008-08-20       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.